Silencing BRAF in these melanomas inhibited MAPK pathway activation, which is illustrated by the reduction of ERK phosphorylation (Fig 3A and 3C), so we tested the involvement of BRAF protein in melanoma-expressed CD70 using a BRAF specific siRNA. The gene discussed is MAPK1; the disease is melanoma.